Sotac Pharmaceuticals Price Movement Clarification
Sotac Pharmaceuticals clarified that recent share price movements are entirely market-driven. The company confirmed it has disclosed all material information in compliance with SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Sotac Pharmaceuticals clarified that recent share price movements are entirely market-driven. The company confirmed it has disclosed all material information in compliance with SEBI regulations.
Sotac's EGM sought shareholder approval to raise authorised share capital from Rs.11.5 crore to Rs.15 crore. The video-conference meeting had one resolution.
Sotac Pharmaceuticals will hold an Extraordinary General Meeting on October 31, 2026, to seek shareholder approval for an increase in the company's authorised share capital.
Sotac Pharmaceuticals approved increasing its authorized share capital to Rs. 15 Crore. An Extra-Ordinary General Meeting will be convened to seek shareholder approval for this change.
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.
Sotac Pharmaceuticals' board approved the 11th AGM for September 30, 2026, and recommended a dividend of Rs. 0.20 per share.